IP Library Granted Patent US 7,374,777
Granted Patent B2
US 7,374,777 · App. 10/610,465 · Granted May 20, 2008

Oriented biopolymeric membrane for meningeal tissue repair

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,374,777
App. No.
10/610,465
Granted
May 20, 2008
Kind
B2
Abstract

A cell occlusion sheet membrane adapted for repairing a damaged meningeal tissue. The sheet membrane contains a layer of cross-linked, oriented biopolymeric fibers that has a thickness of 0.1 mm to 3.0 mm, a density of 0.1 g/cm 3 to 1.2 g/cm 3 , a hydrothermal shrinkage temperature of 45° C. to 80° C., a suture pullout strength of 0.1 kg to 5 kg, a tensile strength of 10 kg/cm 2 to 150 kg/cm 2 , and permeability to molecules having molecular weights of 200 to 300,000 daltons. Also disclosed is a method for making the membrane.

Claims (27)

1. A cell occlusion sheet membrane adapted for the repair of a damaged meningeal tissue comprising a layer of cross-linked, oriented biopolymeric fibers, wherein the membrane has a thickness of 0.1 mm to 3.0 mm, a density of 0.1 g/cm3 to 1.2 g/cm3, a hydrothermal shrinkage temperature of 45° C. to 80° C., a suture pullout strength of 0.1 kg to 5 kg, and a tensile strength of 10 kg/cm2 to 150 kg/cm2, and is permeable to molecules having molecular weights of 200 to 300,000 daltons, wherein the membrane is obtained by cutting a tubular membrane longitudinally and perpendicular to the fiber orientation.

2. The sheet membrane of claim 1 further comprising a second layer of oriented biopolymeric fibers secured to the first layer of oriented biopolymeric fibers, wherein the biopolymeric fibers of the first and second layers are respectively oriented in different directions.

3. The sheet membrane of claim 2 further comprising a third layer of oriented biopolymeric fibers secured to the second layer of oriented biopolymeric fibers, wherein the biopolymeric fibers of the first, second, and third layers are respectively oriented in different directions.

4. The sheet membrane of claim 1 , wherein the biopolymeric fibers are collagen fibers.

5. The sheet membrane of claim 4 further comprising a second layer of oriented collagen fibers secured to the first layer of oriented collagen fibers, wherein the collagen fibers of the first and second layers are respectively oriented in different directions.

6. The sheet membrane of claim 5 further comprising a third layer of oriented collagen fibers secured to the second layer of oriented collagen fibers, wherein the collagen fibers of the first, second, and third layers are respectively oriented in different directions.

7. The sheet membrane of claim 1 , wherein the membrane has a thickness of 0.2 mm to 1.0 mm, a density of 0.2 g/cm3 to 0.8 g/cm3, a hydrothermal shrinkage temperature of 50° C. to 70° C., a suture pullout strength of 0.3 kg to 3 kg, and a tensile strength of 30 kg/cm2 to 80 kg/cm2, and is permeable to molecules having molecular weight cutoff of 70,000 daltons.

8. The sheet membrane of claim 7 further comprising a second layer of oriented biopolymeric fibers secured to the first layer of oriented biopolymeric fibers, wherein the biopolymeric fibers of the first and second layers are respectively oriented in different directions.

9. The sheet membrane of claim 8 further comprising a third layer of oriented biopolymeric fibers secured to the second layer of oriented biopolymeric fibers, wherein the biopolymeric fibers of the first, second, and third layers are respectively oriented in different directions.

10. The sheet membrane of claim 4 , wherein the membrane has a thickness of 0.2 mm to 1.0 mm, a density of 0.2 g/cm3 to 0.8 g/cm3, a hydrothermal shrinkage temperature of 50° C. to 70° C., a suture pullout strength of 0.3 kg to 3 kg, and a tensile strength of 30 kg/cm2 to 80 kg/cm2, and permeable to molecules having molecular weight cutoff of 70,000 daltons.

11. The sheet membrane of claim 10 further comprising a second layer of oriented collagen fibers secured to the first layer of oriented collagen fibers, wherein the collagen fibers of the first and second layers are respectively oriented in different directions.

12. The sheet membrane of claim 11 further comprising a third layer of oriented collagen fibers secured to the second layer of oriented collagen fibers, wherein the collagen fibers of the first, second, and third layers are respectively oriented in different directions.

13. The sheet membrane of claim 1 further comprising a bioactive agent.

14. The sheet membrane of claim 4 further comprising a bioactive agent.

15. The sheet membrane of claim 7 further comprising a bioactive agent.

16. The sheet membrane of claim 10 further comprising a bioactive agent.

17. A method of making a cell occlusion single-layer sheet membrane of oriented biopolymeric fibers, said method comprising:

reconstituting biopolymeric fibers dispersed in a solution;

placing the reconstituted biopolymeric fibers around a mandrel;

rotating the mandrel to convert the reconstituted biopolymeric fibers on the mandrel into a tubular membrane of oriented biopolymeric fibers;

cutting the tubular membrane longitudinally and perpendicular to the fiber orientation;

rolling the cut membrane into a tubular form that is an inversion of the tubular membrane;

inserting the rolled membrane into a tubular mesh; and

crosslinking the biopolymeric fibers, thereby forming a sheet membrane of oriented biopolymeric fibers.

18. The method of claim 17 , wherein the biopolymeric fibers are collagen fibers.

19. The sheet membrane prepared by the method of claim 17 .

20. The sheet membrane prepared by the method of claim 18 .

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Jan 26, 2026
From: GOLUB CAPITAL MARKETS LLC, AS ADMINISTRATIVE AGENT
To: COLLAGEN MATRIX, INC.
Reel/Frame 073583/0580 →
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT R/F 049933/0378 Recorded Aug 1, 2024
From: THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY
To: COLLAGEN MATRIX, INC.
Reel/Frame 068256/0450 →
SECURITY INTEREST Recorded Aug 1, 2019
From: COLLAGEN MATRIX, INC.
To: THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY
Reel/Frame 049933/0378 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Aug 1, 2019
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COLLAGEN MATRIX, INC.
Reel/Frame 049934/0317 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Aug 1, 2019
From: COLLAGEN MATRIX, INC.
To: GOLUB CAPITAL, LLC
Reel/Frame 051594/0368 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 14, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037111/0808 →
SECURITY INTEREST Recorded Oct 23, 2014
From: COLLAGEN MATRIX, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 034021/0474 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2006
From: LI, SHU-TUNG; YUEN, DEBBIE; HANSEN, PEGGY
To: COLLAGEN MATRIX, INC.
Reel/Frame 017255/0115 →